Ping Gu
Impact in
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery
- Pharmaceutical Science top 2%
- Advanced Drug Delivery Systems
Papers in
-
- Retinal Diseases and Treatments 11
-
- Bone Tissue Engineering Materials 15
- Nanoplatforms for cancer theranostics 5
- Co-authors
- Xianqun Fan (35 shared papers)Jipeng Li (3 shared papers)Muyue Yang (3 shared papers)Huifang Zhou (18 shared papers)Zhimin Tang (11 shared papers)Yuan Deng (8 shared papers)Huiqin Gao (11 shared papers)Yahan Ju (17 shared papers)
- Journals
- Investigative Ophthalmology & Visual Science (4 papers)The Journal of Clinical Endocrinology & Metabolism (4 papers)Biomaterials (3 papers)Cancer Management and Research (2 papers)Science Advances (2 papers)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Ping Gu
77 papers receiving 3.4k citations
Ping Gu's Hit Papers
Peers
Comparison fields: 5 of 99
- Biomaterials 386
- Pharmaceutical Science 213
- Ophthalmology 281
- Genetics 222
- Biomedical Engineering 764
Countries citing papers authored by Ping Gu
This map shows the geographic impact of Ping Gu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ping Gu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ping Gu more than expected).
Fields of papers citing papers by Ping Gu
This network shows the impact of papers produced by Ping Gu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ping Gu. The network helps show where Ping Gu may publish in the future.
Co-authors
The 25 scholars most cited alongside Ping Gu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 79 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The application of nanoparticles in cancer immunotherapy: Targeting tumor microenvironment Hit paper breakdown → | 2020 | 597 |
| 2 | HO-1-mediated ferroptosis as a target for protection against retinal pigment epithelium degeneration Hit paper breakdown → | 2021 | 279 |
| 3 | 2015 | 137 | |
| 4 | 2020 | 128 | |
| 5 | 2013 | 113 | |
| 6 | 2019 | 104 | |
| 7 | 2015 | 98 | |
| 8 | 2022 | 93 | |
| 9 | 2020 | 91 | |
| 10 | 2016 | 87 | |
| 11 | 2011 | 85 | |
| 12 | 2014 | 85 | |
| 13 | 2020 | 83 | |
| 14 | 2017 | 74 | |
| 15 | 2018 | 70 | |
| 16 | 2023 | 70 | |
| 17 | 2020 | 68 | |
| 18 | 2022 | 58 | |
| 19 | 2017 | 55 | |
| 20 | 2015 | 54 |
About Ping Gu
Ping Gu is a scholar working on Ophthalmology, Biomedical Engineering, Pulmonary and Respiratory Medicine, Molecular Biology and Pharmaceutical Science, having authored 79 papers that have together received 3.4k indexed citations. Recurring topics across this work include Retinal Development and Disorders (15 papers), Bone Tissue Engineering Materials (15 papers), Retinal Diseases and Treatments (11 papers), Lung Cancer Treatments and Mutations (7 papers), Ophthalmology and Eye Disorders (6 papers), Advanced Drug Delivery Systems (5 papers), Nanoplatforms for cancer theranostics (5 papers) and Mesenchymal stem cell research (4 papers). The work is most often cited by research in Biomaterials (386 citations), Pharmaceutical Science (213 citations), Ophthalmology (281 citations), Genetics (222 citations) and Biomedical Engineering (764 citations). Ping Gu has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Xianqun Fan, Jipeng Li, Muyue Yang, Huifang Zhou, Zhimin Tang, Yuan Deng, Huiqin Gao, Yahan Ju, Dandan Zhang and Sijie Fang. Their work appears in journals such as Investigative Ophthalmology & Visual Science, The Journal of Clinical Endocrinology & Metabolism, Biomaterials, Cancer Management and Research and Science Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.